Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 8 M9 M11 M8 M8 M10 M 37 M Research & development —————— — Operating income 289 M211 M238 M252 M202 M160 M 852 M Non-Operating Income, Total -373 M-444 M-416 M-408 M-337 M-391 M -1.55 B Interest expense, net of interest capitalized 186 M188 M209 M210 M213 M214 M 846 M Non-Operating Income, excl. Interest Expenses -559 M-632 M-625 M-618 M-550 M-605 M -2.4 B Unusual income/expense —————— — Pretax income -92 M-241 M-187 M-165 M401 M-231 M -182 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 241 M361 M404 M293 M92 M171 M 960 M Discontinued operations —————— — Net income 241 M361 M404 M293 M92 M171 M 960 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 241 M361 M404 M293 M92 M171 M 960 M Basic earnings per share (Basic EPS) 0.360.520.570.410.130.24 1.35 Diluted earnings per share (Diluted EPS) 0.360.520.570.410.130.24 1.35 Average basic shares outstanding 676 M695 M709 M699 M718 M718 M — Diluted shares outstanding 676 M695 M709 M699 M718 M718 M — EBITDA 293 M215 M243 M256 M208 M— — EBIT 289 M211 M238 M252 M202 M160 M 852 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 4 M4 M5 M4 M6 M— —